IDEX (IEX) Q2 2026 Earnings Call Transcript
IDEX (IEX) Q2 2026 earnings call reported organic revenue growth of 5% and organic orders up 28%. HST led with 47% organic order growth and 12% organic revenue growth. Adjusted EPS was $2.32, above guidance $2.07 to $2.12, and adjusted EBITDA margin rose 70 bps. Free cash flow was $177M, liquidity over $1.1B, and $77M share repurchases. IEEPA tariff refunds added a $0.08 EPS benefit.
How this was made
The 30-second read
Why it matters
Traders can update valuation and positioning based on the beat versus guidance, the raised full-year 2026 outlook, and the quantified organic order growth led by Health and Science Technologies (HST). The call also provides a quantified tariff-refund benefit to EPS and EBITDA margin, informing how much of the beat is recurring versus policy-driven.
Market read
A guidance-updating earnings call with quantified beats and an explicit full-year outlook raise, plus segment order momentum tied to data center, semiconductor, and space and defense.
What to watch
The transcript emphasizes order growth and backlog visibility, but it does not quantify the magnitude of the full-year outlook raise or provide detailed segment revenue/margin guidance in the excerpt, which could limit how far estimates can move.
Background
The article is a transcript of IDEX’s Q2 2026 earnings call, covering orders, segment performance, margin drivers, tariff refund impacts, free cash flow, buybacks, and the updated full-year outlook.
Ticker impact
IDEX reported Q2 2026 results and raised its full-year 2026 outlook after 28% organic order growth and margin expansion.
Likely positive bias for IDEX shares as traders focus on raised 2026 outlook, strong HST order momentum, and EBITDA margin expansion excluding IEEPA.
The article includes multiple primary, decision-relevant datapoints: Q2 adjusted EPS of $2.32 vs guided $2.07 to $2.12, organic revenue growth and order growth, free cash flow, share repurchases, and an explicit statement that the company raised its full-year 2026 financial outlook based on year-to-date orders and backlog.
Market effects
Strength in HST demand tied to data center, semiconductor, and space and defense can reinforce positive sentiment for industrial components exposed to those end markets.
No explicit regional demand signal beyond U.S. tariff refund mechanics.
Tariff refund accounting (IEEPA) and semiconductor/data-center capex themes may influence broader industrial supply-chain sentiment.
Counterpoint
The EPS and margin benefits include a quantified IEEPA-related tailwind; excluding it, results are still strong but the quality of the beat may be less durable if tariff dynamics reverse.
Key entities
- companyIDEX
Reported Q2 2026 results, 28% organic order growth, margin expansion, free cash flow, share repurchases, and raised full-year 2026 outlook.
- segmentHST
Health and Science Technologies segment, led orders with 47% organic growth and strong margin flow-through.
- policy/accountingIEEPA tariff refunds
U.S. government tariff refunds and related interest, with a stated net benefit to adjusted EPS and EBITDA margin.
